Risk of injury associated with the sedative potential of second‐generation antihistamines: A nationwide retrospective cohort study
British Journal of Clinical Pharmacology · 2026
DOI: 10.1002/bcp.70505 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift British Journal of Clinical Pharmacology, 2026. Verfasst von Jumpei Taniguchi und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Epidemiology and Health Economics, School of Public Health, The University of Tokyo, Tokyo, Japan. Hauptthemen laut MEDLINE: Hypnotics and Sedatives, Histamine H1 Antagonists, Non-Sedating, Rhinitis, Allergic, Seasonal. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Aim
Individual second‐generation antihistamines may possess differential sedative potential due to the variability in central histamine receptor H1 occupancy. This study aimed to evaluate whether the sedative potential of second‐generation antihistamines is associated with the risk of injury during Japan's pollen season.
Methods
We conducted a retrospective cohort study using data acquired from a nationwide health insurance claims database in Japan. We enrolled patients with allergic rhinitis who were newly prescribed oral second‐generation antihistamines during the pollen season (January–May) between 2006 and 2022. Antihistamines were categorized into two groups based on the estimated central histamine receptor H1 occupancy: ≥ 10% (higher‐sedation group: cetirizine, levocetirizine, loratadine, olopatadine and bepotastine) and < 10% (lower‐sedation group: fexofenadine, bilastine and desloratadine). The proportions of newly diagnosed injuries during the same pollen season were compared between the higher‐sedation and lower‐sedation groups using propensity score overlap weighting. Subgroup analysis that stratified patients by age (< 65 and ≥ 65 years) was also conducted.
Results
Among 1 313 550 eligible patients, 50.2% and 49.8% received higher‐sedation and lower‐sedation antihistamines, respectively. After overlap weighting, no significant difference in injury risk was observed between the groups (2.6% vs . 2.6%; risk difference, −0.0%; 95% confidence interval, −0.1 to 0.0; P = 0.388). Subgroup analysis showed consistent results across the age groups.
Conclusion
In this large nationwide cohort of patients with allergic rhinitis, second‐generation antihistamines with higher vs . lower sedative potential showed no difference in injury risk during Japan's pollen season.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Epidemiology and Health Economics, School of Public Health, The University of Tokyo, Tokyo, Japan.
- Department of Health Services Research, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
ORCID-Profile: Jumpei Taniguchi, So Sato
Zitieren
APA
Taniguchi, J., Aso, S., Sato, S., & Yasunaga, H. (2026). Risk of injury associated with the sedative potential of second‐generation antihistamines: A nationwide retrospective cohort study. British Journal of Clinical Pharmacology. https://doi.org/10.1002/bcp.70505
Vancouver
Taniguchi J, Aso S, Sato S, Yasunaga H. Risk of injury associated with the sedative potential of second‐generation antihistamines: A nationwide retrospective cohort study. British Journal of Clinical Pharmacology. 2026. doi:10.1002/bcp.70505
BibTeX
@article{Taniguchi2026,
author = {Taniguchi, Jumpei and Aso, Shotaro and Sato, So and Yasunaga, Hideo},
title = {Risk of injury associated with the sedative potential of second‐generation antihistamines: A nationwide retrospective cohort study},
journal = {British Journal of Clinical Pharmacology},
year = {2026},
doi = {10.1002/bcp.70505}
}
EUVIMED